Modest increase in drug costs can lead to increase in mortality

Cost-sharing can affect patient choices and, ultimately, patient health according to a new study by the National Board of Economic Research (NBER). The study found “that a relatively modest increase in drug costs ($10 per prescription) lead to a 33 percent increase in mortality.” The researchers wrote, “We trace this mortality effect to cutbacks in life-saving medicines like statins and antihypertensives, for which clinical trials show large mortality benefits.” Read the article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org